Alan Bentley
Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics
Feb. 25, 2021—A new partnership between Vanderbilt University’s Warren Center for Neuroscience Drug Discovery and clinical stage biopharmaceutical company Soleno Therapeutics will further research into new clinical treatments for multiple obesity syndromes.
Center for Technology Transfer & Commercialization breaks records in rapid facilitation of COVID-19 related agreements
Jul. 9, 2020—To keep pace with Vanderbilt researchers developing COVID-19 solutions, the Center for Technology Transfer & Commercialization has facilitated three license agreements, 11 patent applications and 43 material transfer agreements in record time.
Vanderbilt continues in top 10 of ‘World’s Most Innovative Universities’
Nov. 2, 2018—Vanderbilt University—for the second consecutive year—has been named the 10th most innovative university in the world, according to a 2018 "Reuters Top 100" analysis.
Forum highlights innovative approaches to bolstering biomedical research
Jun. 1, 2017—How can we — together — make research at Vanderbilt University Medical Center (VUMC) better and stronger?
Student entrepreneurial pitch competition to stream live on SEC Network Sept. 21
Sep. 17, 2015—The SEC Network will provide coverage of the 2015 SEC Symposium, highlighted by a live SEC Network+ stream of the student entrepreneurial pitch competition on Monday, Sept. 21.
VU faculty to join SEC colleagues to discuss creativity, innovation, entrepreneurship
Apr. 27, 2015—Vanderbilt faculty will join colleagues from the other 13 Southeastern Conference universities for a symposium titled “Creativity, Innovation and Entrepreneurship: Driving a 21st-Century Economy” Sept. 20-22 in Atlanta.
Technology Transfer Efforts Gain Steam
Sep. 26, 2014—Vanderbilt signed 101 licensing agreements with industry partners during fiscal year 2014, nearly 20 more than the record total set last year. Many transactions were in medical diagnostics, health care information technology, pharmaceutics, oncology and biotechnology.
VU’s technology transfer efforts gain steam
Jul. 24, 2014—Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year.
New system helps speed transfer of research materials
Mar. 20, 2014—Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research.
VU’s technology commercialization efforts make strides
Sep. 26, 2013—Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.
Wireless ECG invented at VU seeks ‘Jumpstart’ from business acceleration program
May. 30, 2013—A wireless electrocardiogram (ECG) invented at Vanderbilt University is the centerpiece of a startup company that has been chosen to be a part of the Jumpstart Foundry Class of 2013.
Technology transfer efforts bolstered by recent agreements
Mar. 28, 2013—Last month, Vanderbilt University announced a collaboration agreement with GlaxoSmithKline, a leading pharmaceutical and consumer health care company, to develop potential new drugs for severe obesity.